Key result
Persistent AF is linked to ~27% higher post-ablation AF recurrence versus paroxysmal AF.
Why the study?
Data linking real-world ambulatory cardiac monitoring results in AF patients post-ablation is limited, despite guidelines emphasizing AF burden rather than recurrence alone.
What is the rate of AF recurrence, AF burden, and other actionable arrhythmias detected by 14-day ambulatory cardiac monitoring in patients within 1 year after AF ablation?
Cohort (n=11,051)
Yes
What is the rate of AF recurrence, AF burden, and other actionable arrhythmias detected by 14-day ambulatory cardiac monitoring in patients within 1 year after AF ablation?
Answers are grounded in this paper and cite their sources.
In a real-world post-ablation cohort, 14-day ambulatory monitoring detected AF recurrence in 21.4% of patients and other actionable arrhythmias in 44%, highlighting its utility for risk stratification and individualized management.
Background Catheter ablation is an effective rhythm-control strategy for atrial fibrillation (AF) but has significant rates of recurrence. The OCEAN trial recently demonstrated safety of discontinuation of anticoagulation for patients without AF recurrence ≥30 sec, though contemporary guidelines emphasize AF burden rather than recurrence alone as a clinically meaningful measure in post-ablation patients. Ambulatory cardiac monitoring (ACM) enables measurement of AF recurrence timing and burden, and identification of other arrhythmias post-ablation. The ACM evaluated in this study was independently validated to have a correlation of 0.99 with an atrial pacemaker lead in AF burden determination. Data linking real-world ACM results in AF patients post-ablation is limited. Purpose To evaluate AF recurrence, burden, and detection of other clinically relevant arrhythmias in patients undergoing ACM following AF ablation. Methods We retrospectively analyzed 2018-2022 data from US patients ≥18 years monitored ≤14 days with patched-based, continuous ACM within 1-year following AF ablation using commercial fee-for-service and Medicare Advantage claims linked to corresponding clinical monitoring records. AF was classified using ICD-10 codes associated with the ablation procedure as paroxysmal, persistent/permanent, or unspecified. Outcomes included AF recurrence, AF burden, and detection of other arrhythmias. Results Among 11,051 patients, 53% had paroxysmal, 36% persistent/permanent, and 11% unspecified AF. Mean (SD) CHA2DS2-VASc was 2.4 (1.5). Median time from ablation to ACM was 113 days and ranged from 110-120 days across AF types. Overall, 21.4% had recurrent AF ≥30 seconds (lowest for paroxysmal [19.2%] vs. persistent/permanent [24.4%] and unspecified [22.6%]; both p<0.01). Among all post-ablation patients, 78.6% had 0% burden. Among those with burden >0%, median burden was 11.9% (Q1-Q3: 2.0-89.8%), and was markedly lower for paroxysmal (4.4%; Q1-Q3: 1.1-23.2%) compared to permanent/persistent (43.1%; Q1-Q3: 5.1-100%) and unspecified AF (16.8%; Q1-Q3: 2.1-100%). ACM also identified actionable arrhythmias in 44% of patients, including pauses, ventricular tachycardia, AV block, and sustained supraventricular tachycardia in addition to AF (Table). Conclusions In a large real-world cohort of post AF ablation patients monitored with patch-based ambulatory ECG, the proportion free of AF was consistent with prior AF ablation studies. Among those with recurrence, AF burden was substantial and varied by AF severity. The significant rate of sustained SVT suggests residual or new atrial arrhythmogenic activity. These results highlight a sizable population potentially eligible for anticoagulation discontinuation after negative repeat monitoring, based findings from the recent OCEAN trial. For patients with recurrent AF, quantifying burden via 14-day ACM may improve risk stratification and inform individualized management decisions.
No takes yet. Share an insight, caveat, or question.
Ashburner et al. (2026) conducted a cohort in Atrial fibrillation (n=11,051). Persistent/permanent atrial fibrillation vs. Paroxysmal atrial fibrillation was evaluated on recurrent AF ≥30 seconds (p=<0.01). Among patients monitored with ambulatory ECG post-ablation, recurrent AF ≥30 seconds occurred in 24.4% with persistent/permanent AF versus 19.2% with paroxysmal AF.
Synapse has enriched 10 related papers. Consider them for comparative context: